Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Tesla Stock Drops Amid Tariff Woes, Weak Sales, and China Trade Tensions

by Team Lumida
April 11, 2025
in Markets
Reading Time: 4 mins read
A A
0
blue coupe parked beside white wall

Photo by Tesla Fans Schweiz on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Tesla stock fell 7.3% on Thursday, reversing part of its 23% gain on Wednesday, as investors grappled with ongoing tariff concerns and weak sales data.
  • The auto industry still faces 25% tariffs on imported cars and parts, which could raise costs and hurt demand, with Tesla particularly exposed due to its global supply chain.
  • Tesla’s Q1 U.S. EV sales dropped 8.6% year-over-year, with its market share falling by 9 percentage points, while overall EV sales in the U.S. rose 10.6%.
  • China, Tesla’s second-largest market and home to its Shanghai Gigafactory, remains a key risk as U.S.-China trade tensions escalate, with retaliatory tariffs adding pressure.

What Happened?

Tesla stock dropped sharply on Thursday, closing at $252.40, as investors digested the lingering impact of President Trump’s tariffs on the auto industry. While Trump announced a 90-day pause on some tariffs, the 25% levy on imported cars and parts remains in place, creating cost pressures for automakers.

Tesla’s Q1 sales data added to investor concerns. The company sold 128,000 EVs in the U.S., down 8.6% year-over-year, while its global sales fell 13% in the same period. Tesla’s market share in the U.S. EV market dropped by 9 percentage points, reflecting growing competition from rivals like BYD and other automakers.

China, which accounted for over 20% of Tesla’s 2024 sales, poses another challenge. Tesla’s Shanghai Gigafactory is its most productive plant, but escalating U.S.-China trade tensions and retaliatory tariffs could disrupt operations and demand in the region.


Why It Matters?

Tesla faces a trifecta of challenges: tariff-related cost pressures, declining sales, and geopolitical risks in China. The 25% tariffs on imported cars and parts could erode margins, while weak Q1 sales data highlights Tesla’s struggle to maintain its dominance in an increasingly competitive EV market.

China’s importance to Tesla’s growth adds another layer of risk. The Shanghai Gigafactory is critical to Tesla’s global production, and the company’s reliance on the Chinese market makes it vulnerable to trade tensions and local competition from BYD and other EV makers.

Analysts have responded by lowering their price targets for Tesla stock, with the average target now at $341, down $32 over the past month.


What’s Next?

Tesla’s ability to navigate these challenges will depend on its ability to manage costs, maintain market share, and adapt to geopolitical risks. Investors will closely watch for updates on tariff negotiations, as well as Tesla’s Q2 sales performance and its ability to compete in key markets like China.

The broader auto industry will also monitor the impact of tariffs on costs and demand, with hopes that ongoing negotiations could lead to a resolution. For now, Tesla and other automakers remain under pressure as they navigate an uncertain trade and economic environment.

Source
Previous Post

Retirees: Build Your Cash Cushion Amid Market Volatility and Tariff Uncertainty

Next Post

Fed Officials Grapple With Tariff-Induced Uncertainty Amid Inflation and Growth Risks

Recommended For You

Google Bets on California Consolidation to Win the AI Race — Appointing Kavukcuoglu as Hassabis Steps Back, as Researchers Flee to Rivals and Jeff Dean Launches Startup

by Team Lumida
14 hours ago
Alphabet $GOOGL Q2 2024 Results

Google is concentrating its AI leadership in Mountain View, appointing Koray Kavukcuoglu — mentored by Yann LeCun, now the only remaining Gemini co-lead — to run its sprawling...

Read more

Aschenbrenner Returns to Investing With $400 Million Private Bet Days After SA Nearly Collapsed — Got Married Mid-Crisis to Anthropic CEO’s Chief of Staff

by Team Lumida
14 hours ago
Leopold Aschenbrenner’s Situational Awareness Fund Down 67% in July — Citadel Steps In to Buy the AI Stock Portfolio

Leopold Aschenbrenner made a $400 million investment in an undisclosed private company on Tuesday — just days after Situational Awareness nearly buckled under margin calls that collapsed its...

Read more

SoftBank Piles On: $10 Billion Margin Loan Backed by OpenAI Stake Brings Total OpenAI Exposure to ~$65 Billion by October

by Team Lumida
14 hours ago
SoftBank’s Narrow Gain: How AI Investments Shape the Future

SoftBank secured a $10 billion two-year margin loan from Goldman Sachs, JPMorgan, Mizuho, Apollo, and SMBC backed by its OpenAI preferred share stake — adding to the $40...

Read more

The A-List Behind Situational Awareness — D1’s Sundheim, Greenoaks’ Mehta, and Tiger Global’s Dewan Backed a 20-Something With No Track Record on the AI Trade

by Team Lumida
2 days ago
Leopold Aschenbrenner’s Situational Awareness Fund Down 67% in July — Citadel Steps In to Buy the AI Stock Portfolio

WSJ reveals the elite investor roster behind Situational Awareness — the AI hedge fund that lost ~67% in July — which was backed by D1 Capital's Dan Sundheim,...

Read more

SpaceX Spent $15.8 Billion on AI in One Quarter — Doubled Its Prior Spend and Is Just Getting Started

by Team Lumida
2 days ago
SpaceX’s IPO Is So Big It’s Forcing Wall Street to Rewrite Its Own Rules

SpaceX reported $18.4 billion in total Q2 capital expenditures, with $15.8 billion tied specifically to its AI build-out — double the prior quarter — as Elon Musk's rocket...

Read more

Citadel Buys Situational Awareness Public Equities at 10% Discount, Triggering Relief Rally as Fund Assets Collapse From $45B to $10B

by Team Lumida
2 days ago
Ken Griffin Warns Trump-Era Political вмешening Is Distorting Corporate Decision-Making

Ken Griffin's Citadel purchased Situational Awareness's public equity portfolio at a 10% discount, triggering a relief rally across SA's former holdings as the fund's assets collapsed from $45...

Read more

Caterpillar Surges 11% as Data Center Power Demand Drives Record $72 Billion Backlog — AI Infrastructure Is Now CAT’s Biggest Business

by Team Lumida
2 days ago
a bulldozer in a dirt field

Caterpillar crushed Q2 estimates — $8.17 EPS vs. $6.17 expected, $20.5B revenue vs. $19B expected — as its power and energy unit, which makes generators and turbines for...

Read more

Apple’s Worst Day Since Tariffs, Microsoft’s Best Day Ever — Big Tech Earnings Split the Market as New Fed Chair Leaves Investors “Doved and Confused”

by Team Lumida
4 days ago
close-up photo of monitor displaying graph

A week of blockbuster tech earnings sent stocks sharply in opposite directions: Microsoft notched the largest single-session market cap gain in US history while Apple suffered its worst...

Read more

AstraZeneca Explores Mega-Merger With Bristol-Myers Squibb — Would Be Largest Pharma Deal in History at $107 Billion Combined RevenueAstraZenecaAstraZeneca Explores Mega-Merger With Bristol-Myers Squibb — Would Be Largest Pharma Deal in History at $107 Billion Combined Revenue

by Team Lumida
4 days ago
vitamin b 12 100 mg

AstraZeneca has held early-stage talks with Bristol-Myers Squibb about a potential combination that would create the world's largest drugmaker — a deal analysts say would be hard to...

Read more

Morgan Stanley Upgrades Korea to Overweight, Sees 36% Upside — “Leverage Washout” Creates Entry Point Into AI and Industrial Super-Cycle

by Team Lumida
4 days ago
Morgan Stanley Q2 2024 Earnings Summary

Morgan Stanley upgraded the Kospi to overweight with a 9,000 target — 36% above current levels — arguing that the index's 30%+ selloff from its June peak reflects...

Read more
Next Post
Will September’s Fed Rate Cuts Surprise Investors? Here’s What Deutsche Bank Predicts

Fed Officials Grapple With Tariff-Induced Uncertainty Amid Inflation and Growth Risks

Fed Official Warns of Inflation Risks Under Trump Presidency

Trump Administration Races to Secure Tariff Deals With Over 70 Countries Amid Trade War

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

China’s Bold Economic Moves: What You Need to Know Now

A Chinese Factory Comes to Ohio—and Exposes the Limits of “Onshoring”

February 9, 2026
Why Hurricane Helene Means Trouble for Your Insurance Claims

Why Hurricane Helene Means Trouble for Your Insurance Claims

October 8, 2024
New York Grants Cumberland BitLicense: What This Means for Crypto Markets

New York Grants Cumberland BitLicense: What This Means for Crypto Markets

June 18, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018